NDC 68071-4512-02 - Levofloxacin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
68071-4512
Requested NDC
68071-4512-02
Package NDCs from labels
68071-4512-3, 68071-4512-2, 68071-4512-1, 68071-4512-02
Manufacturer
NuCare Pharmaceuticals,Inc.
Effective date
2024-06-10
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Levofloxacin - NuCare Pharmaceuticals,Inc.NuCare Pharmaceuticals,Inc.2024-06-10HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68071-4512-1Levofloxacin1 in 1 BOTTLETABLET, FILM COATED17
68071-4512-2Levofloxacin2 in 1 BOTTLETABLET, FILM COATED27
68071-4512-3Levofloxacin3 in 1 BOTTLETABLET, FILM COATED37

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68071-4512LEVOFLOXACIN TABLET, FILM COATED [NUCARE PHARMACEUTICALS,INC.]7Current NDC, Legacy NDC, 3 package rows20240612_72cb9372-e9f8-3ca1-e053-2a91aa0ad820.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 116 · 2,313 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HERA SILKYSTAY FOUNDATION 44C1TITANIUM DIOXIDEAmorepacific Corporation5f42d960-6b86-b4cd-e063-6294a90a98f32026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 45N1TITANIUM DIOXIDEAmorepacific Corporation5f4326fc-b3c3-1a8b-e063-6294a90a8d9b2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 45W1TITANIUM DIOXIDEAmorepacific Corporation5f4335c8-596f-3269-e063-6294a90a6c3d2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 46W1TITANIUM DIOXIDEAmorepacific Corporation5f43404e-bdab-3f4b-e063-6294a90ab8812026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 47N1TITANIUM DIOXIDEAmorepacific Corporation5f435148-dcb1-cfdf-e063-6394a90aa8b62026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 50N1TITANIUM DIOXIDEAmorepacific Corporation5f43610f-6c4f-dd9d-e063-6394a90ab60a2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 48N1TITANIUM DIOXIDEAmorepacific Corporation5f4372c4-b87a-91ab-e063-6294a90a68072026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 49C1TITANIUM DIOXIDEAmorepacific Corporation5f4380d1-2cf4-1fd8-e063-6394a90a0aa32026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA BLACK CUSHION FOUNDATION 13N1OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDEAmorepacific Corporation5aff3d25-d034-0815-e063-6294a90a86642026-10-29WarningsExact identifier
unii: 15FIX9V2JP
LevofloxacinLEVOFLOXACINSt. Mary's Medical Park Pharmacy46a3c619-b2a3-3f28-e063-6394a90a23092026-10-29Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA202801
rxcui: 311296
unii: 6GNT3Y5LMF
Blue Lizard Sensitive SPF 50 SunscreenTITANIUM DIOXIDE AND ZINC OXIDECrown Laboratories32d78048-d281-1d80-e063-6394a90aec192026-10-28WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 32W1TITANIUM DIOXIDEAmorepacific Corporation5eed2165-afc2-6958-e063-6294a90add582026-10-28WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 34O1TITANIUM DIOXIDEAmorepacific Corporation5eedd87b-a7b1-1abc-e063-6294a90ae29e2026-10-28WarningsExact identifier
unii: 15FIX9V2JP
LevofloxacinLEVOFLOXACINA-S Medication Solutionsf6a7b23e-7a25-48fb-a9e4-ccebfc6551602026-10-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 199885
rxcui: 311296
rxcui: 199884
unii: 6GNT3Y5LMF
LevofloxacinLEVOFLOXACINPD-Rx Pharmaceuticals, Inc.d98cf024-51fa-45a1-b247-da55aba88ca02026-10-27Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA202801
rxcui: 311296
unii: 6GNT3Y5LMF
HERA SILKYSTAY FOUNDATION 26N1TITANIUM DIOXIDEAmorepacific Corporation5ec7151e-4f83-4aca-e063-6294a90a98182026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 26W1TITANIUM DIOXIDEAmorepacific Corporation5ec7276d-fcaf-65b2-e063-6394a90ac2202026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 28C1TITANIUM DIOXIDEAmorepacific Corporation5ec73566-5d67-7153-e063-6394a90aba332026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 28N1TITANIUM DIOXIDEAmorepacific Corporation5ec75100-153c-80cd-e063-6294a90a6d512026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 28O1TITANIUM DIOXIDEAmorepacific Corporation5ec77f7a-4621-ac0c-e063-6294a90a3f702026-10-26WarningsExact identifier
unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.